| SC 13G | 2022-05-25 | PURA VIDA INVESTMENTS, LLC | Pulmonx Corp | 1,878,122 | 5.1% | EDGAR |
| SC 13G/A | 2022-02-11 | Yu Fan | Pulmonx Corp | 31,903 | 0.1% | EDGAR |
| SC 13G/A | 2022-02-11 | Flynn James E | Pulmonx Corp | 2,366,867 | 6.4% | EDGAR |
| SC 13G | 2022-02-11 | Champlain Investment Partners, LLC | Pulmonx Corp | 2,087,145 | 5.7% | EDGAR |
| SC 13G | 2022-02-11 | Capital World Investors | Pulmonx Corp | 2,754,500 | 7.5% | EDGAR |
| SC 13G/A | 2022-02-10 | PRIMECAP MANAGEMENT CO/CA/ | Pulmonx Corp | 4,943,891 | 13.4% | EDGAR |
| SC 13G | 2022-02-10 | VANGUARD GROUP INC | Pulmonx Corp | 2,524,488 | 6.8% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | Pulmonx Corp | 2,718,331 | 7.4% | EDGAR |
| SC 13G/A | 2022-02-03 | BOSTON SCIENTIFIC CORP | Pulmonx Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-12-09 | PRIMECAP MANAGEMENT CO/CA/ | Pulmonx Corp | 4,323,303 | 11.7% | EDGAR |
| SC 13G | 2021-07-16 | Flynn James E | Pulmonx Corp | 1,950,887 | 5.4% | EDGAR |
| SC 13G/A | 2021-02-12 | Yu Fan | Pulmonx Corp | 833,333 | 2.3% | EDGAR |
| SC 13G | 2021-02-12 | BOSTON SCIENTIFIC CORP | Pulmonx Corp | 5,988,106 | 16.8% | EDGAR |
| SC 13G | 2020-10-13 | Yu Fan | Pulmonx Corp | 833,333 | 2.5% | EDGAR |